SIXTH AMENDMENT TO LEASE (Myriad Genetics: Phase I)Lease • May 4th, 2016 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 4th, 2016 Company IndustryThis Sixth Amendment to Lease (this “Amendment”) is made and entered into as of February 3rd, 2016, by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”), and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”).
SECOND AMENDMENT TO LEASE (Myriad Genetics: Phase III)Lease • May 4th, 2016 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 4th, 2016 Company IndustryThis Second Amendment to Lease (this “Amendment”) is made and entered into as of February 3rd, 2016, by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”), and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”).
FIFTH AMENDMENT TO LEASE (Myriad Genetics: Phase II)Lease • May 4th, 2016 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMay 4th, 2016 Company IndustryThis Fifth Amendment to Lease (this “Amendment”) is made and entered into as of February 3rd, 2016, by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”), and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”).